GVR Report cover Negative Pressure Wound Therapy Market Size, Share & Trends Report

Negative Pressure Wound Therapy Market Size, Share & Trends Analysis Report By Product (Conventional NPWT, Single-use NPWT), By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers), By End Use, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-1-68038-208-2
  • Number of Pages: 90
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2020
  • Industry: Healthcare

Report Overview

The global negative pressure wound therapy market size was valued at USD 2.0 billion in 2021 and is expected to witness a compound annual growth rate (CAGR) of 6.7% from 2022 to 2030. Increasing demand for advanced wound care is expected to drive the market for Negative Pressure Wound Therapy (NPWT). Single-use NPWT devices are gaining traction in the field of wound care management over conventional products. For instance, major players like Smith & Nephew introduced a single-use NPWT, PICO, which has gained huge acceptability worldwide. The increasing prevalence of chronic diseases, such as diabetes, is anticipated to impact the industry demand to a large extent. This is primarily attributable to the fact that diabetes often results in complications such as diabetic foot ulcers.

China negative pressure wound therapy market size, by wound type, 2020 - 2030 (USD Million)

The rapid spread of the COVID-19 virus has led to a global pandemic, triggering the disruption of healthcare services, including the medical care of patients with wounds. Due to the need, the provision of wound care, which ought to be viewed as a fundamental clinical service, has shifted drastically. During the pandemic, the major objectives of negative pressure wound therapy shifted from complete healing of wounds to avoiding serious complications to minimize surgery and hospitalization. Due to the effect of the pandemic on major manufacturers, production has significantly reduced causing an increase in the costs of wound dressings.

The majority of wounds are caused by transport injuries and road accidents are one of the major drivers of the market. Since the pandemic brought about the complete cancellation of public and private transportation, the number of patients with wounds requiring medical care has significantly reduced. Overall, we can say that the COVID-19 pandemic has had a negative impact on the market. The incidence of diabetic ulcers among the U.S. population has been estimated to be 2% annually, which is expected to support the growth of the market. In addition, traumatic events are on the rise in regions such as the Asia Pacific. Burns lead to the complete destruction of the skin rendering the wound bed dry. Therefore, an increasing number of such traumatic wounds is projected to boost the demand for wound therapeutics and subsequently the market.

End-use Insights

The hospital segment dominated the market and accounted for the largest revenue share of 52.5% in 2021 owing to the fact that conventional devices are widely used in hospital settings. The home care setting is projected to be the fastest-growing segment with the highest CAGR during the forecast period. NPWT therapy for homecare settings is emerging with the introduction of single-use NPWT systems. These products eliminate the need for hospital stays and hence render the overall therapy cost-effective with its usage at home.

Wound Type Insights

The pressure ulcer segment dominated the market and accounted for the largest revenue share of 31.3% in 2021 owing to longer treatment duration. Patients with pressure ulcers have to stay for longer durations when admitted to hospitals, thereby increasing hospital costs. Another factor contributing to such growth is its emerging application in treating pressure wounds such as bedsores. On the other hand, the diabetic foot ulcers segment is projected to witness the highest CAGR during the forecast period owing to its huge success rate in treating NPWT as well as the high prevalence of diabetes. Diabetic foot ulcers are the most common types of chronic wounds and NPWT expedites the healing process of such wounds. The other wound types, among others, include arterial ulcers and surgical wounds.

Product Insights

The conventional devices segment accounted for the largest revenue share of 88.0% in 2021 owing to their high price and increasing adoption. Such systems require hospital admission and are not suitable for homecare settings as they involve the use of heavy canisters. These devices can be rented as well as purchased, which is expected to increase the usage rate of NPWT in developing countries owing to its low purchasing power.

Global negative pressure wound therapy market share, by product, 2021 (%)

The single-use NPWT devices segment is expected to witness a lucrative CAGR during the forecast period. This is due to their wide applicability in home care settings, which has prompted major companies to focus on increasing their cost-effectiveness. This has proved to be an added advantage for single-use NPWT devices in developing countries.

Regional Insights

North America held the largest revenue share of 38.9% in 2021 owing to rising healthcare expenditure and highly developed healthcare infrastructure in this region. This has led to greater adoption of NPWT devices in both hospitals as well as homecare settings. In the Asia Pacific, the market is anticipated to show a lucrative CAGR during the forecast period. This is mainly due to the increasing number of traumatic events such as burns which in turn is triggering the demand for therapy in this region.

Key Companies & Market Share Insights

The companies are focusing on mergers, acquisitions, new product development, and strategic collaboration strategies. For instance, in 2016, Acelity entered into a partnership agreement with Mediq with an aim to distribute its product offerings in advanced wound therapeutics and regenerative medicine in Finland, Denmark, Sweden, and Norway. In addition, ConvaTec launched Avelle NPWT System in the U.K. in 2016. These are advancing superior technologies, which are expected to foster the market growth in the long run. Some of the prominent players in the negative pressure wound therapy market include:

  • Acelity L.P. Inc.

  • Talley Group Limited

  • Nephew plc

  • Devon Medical Products

  • Mölnlycke Health Care

  • Medela

  • DeRoyal Industries, Inc.

  • ConvaTec, Inc.

  • Cardinal Health, Inc.

  • Paul Hartmann AG

Negative Pressure Wound Therapy Market Report Scope

Report Attribute


Market size value in 2022

USD 2.3 billion

Revenue forecast in 2030

USD 3.8 billion

Growth Rate

CAGR of 6.7% from 2022 to 2030

Base year for estimation


Historical data

2018 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million and CAGR from 2018 to 2030

Report coverage        

Revenue forecast, company share, competitive landscape, growth factors and trends

Segments covered

Product, wound type, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; India; China; Brazil; Mexico; South Africa

Key Companies profiled

Acelity L.P. Inc.; Talley Group Limited; Nephew plc; Devon Medical Products; Mölnlycke Health Care; Medela; DeRoyal Industries, Inc.; ConvaTec, Inc.; Cardinal Health, Inc.; Paul Hartmann AG

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional, and segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global negative pressure wound therapy market report based on product, wound type, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)

    • Conventional NPWT

    • Single-use NPWT

  • Type Outlook (Revenue, USD Million, 2018 - 2030)

    • Diabetic Foot Ulcers

    • Venous Leg Ulcers

    • Pressure Ulcers

    • Burn Wounds

    • Others

  • End-use Outlook (Revenue, USD Million, 2018 - 2030)

    • Hospitals

    • Homecare

    • Others

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon